Home/Addimmune/Jeff Galvin

JG

Jeff Galvin

CEO of AGT and Addimmune

Therapeutic Areas

Infectious Disease

Addimmune Pipeline

Drug	Indication	Phase
AGT103-T	HIV Infection (Functional Cure)	Phase 1

Leadership Team at Addimmune

Marcus Conant, MD

Chief Medical Officer

Barry Wells, MD

Head of Business Development

View full Addimmune profile